MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0020322
Provet Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.73 Cr
▲ 35% YoY
Net profit · FY 2025
₹1.3 Cr
Net margin 1.3%
EBITDA · FY 2025
₹4.43 Cr
EBITDA margin 4.4%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹26.03 Cr
Satisfied ₹24.53 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
116
Provident fund records
About Provet Pharma Private Limited
Data last updated:
Provet Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 14 October 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2009PTC073198. Its GSTIN is 33AAFCP2048B1ZZ (Tamil Nadu). The company holds 9 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Muthu Selvan Vengan (Managing Director) and Suthanthirakumar Senthil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.73 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹1.3 Cr (net margin 1.3%) and EBITDA of ₹4.43 Cr (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over five years.
The company has about 116 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Provet Pharma. As per MCA filings, the company has open charges of ₹26.03 Cr and satisfied charges of ₹24.53 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.09 Cr; the latest was in March 2015. Its 7 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Panchsheel Organics Limited with revenue of ₹107.68 Cr.
Provet Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0020322). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website provet.in.
Company details
CIN U24231TN2009PTC073198
Registration Number 073198
Incorporation Date 14 October 2009
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0020322
Recognitions & Rankings of Provet Pharma
Contact details
Provet Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is provet.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address9 1st Floor 2nd Lane Chakrapani Street Narasingapuram Extn. Maduvankarai Guin, Dy, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Provet Pharma Private Limited, buy the company report.
Comprehensive company report
Provet Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Provet Pharma operates one associated brand: Provet Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Producer and supplier of animal feed and nutrition products | provet.in |
Business activity
The main business activity of Provet Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Provet Pharma Private Limited, buy the company report.
Financials of Provet Pharma Private Limited
FY 2025 filings availableProvet Pharma Private Limited reported revenue of ₹100.73 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹100.73 Cr ▲ 35%
Net profit · FY 2025
₹1.3 Cr margin 1.3%
EBITDA · FY 2025
₹4.43 Cr margin 4.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 25%
5 years · compounded
▼ 1%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 35% growth in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.3 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Provet Pharma Private Limited, buy the company report.
Board of directors of Provet Pharma Private Limited
Provet Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muthu Selvan Vengan Also directs: Avantiva Animal Health Private Limited | Managing Director | 14 Oct 2009 | 17 Years 0 Months | Current |
| Suthanthirakumar Senthil Also directs: Avantiva Animal Health Private Limited | Director | 14 Oct 2009 | 17 Years 0 Months | Current |
Peer comparison
Provet Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India | |||
| Ayurvet Limited | ₹107.61 Cr (FY 2023) | 3.0% | Ahmedabad, Gujarat, India | |||
| Indovax Private Limited | ₹105 Cr (FY 2024) | 6.0% | New Delhi, Delhi, India | |||
| Provet Pharma Private Limitedthis company | ₹100.73 Cr (FY 2025) | ₹1.3 Cr | 1.3% | 35.0% | 116 | Chennai, Tamil Nadu, India |
| Baader Schulz Laboratories Private Limited | ₹95.24 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Micro Animal Health Care Private Limited | ₹88.47 Cr (FY 2024) | 86.0% | Bangalore, Karnataka, India | |||
| Vetsfarma Limited | ₹85.2 Cr (FY 2025) | 13.0% | Jalandhar, Punjab, India | |||
| Vivaldis Health and Foods Private Limited | ₹81.41 Cr (FY 2025) | 34.0% | Pune, Maharashtra, India |
To see the full peer comparison of Provet Pharma Private Limited, buy the company report.
Auditor
Provet Pharma Private Limited is audited by Raghavan & Krishnasami for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Raghavan & Krishnasami | FY 2023 | 003320S |
Shareholding
The shareholding of Provet Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Provet Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.03 Cr
Satisfied charges
₹24.53 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Dec 2021 | 100521181 | Hdfc Bank Limited | ₹26.03 Cr | Open | |
| 02 Mar 2022 | 100560773 | Others | ₹2.5 Cr | Satisfied | |
| 07 Mar 2017 | 100107021 | Others | ₹16.03 Cr | Satisfied | |
| 28 Apr 2010 | 10218570 | Indian Bank | ₹6 Cr | Satisfied |
To see the full charge records of Provet Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Provet Pharma Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.09 Cr; the latest was in March 2015.
Total deals
4
Funding rounds
3
Secondary share transfer
1
Disclosed funding
₹1.09 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Mar 2015 | Funding round | ₹80 Lakh | Investors: 4 individuals |
| Sep 2012 | Funding round | ₹20 Lakh | Investors: an individual |
| Mar 2010 | Funding round | ₹9 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Provet Pharma Private Limited has 2 court cases on record: 2 filed by Provet Pharma. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Civil suit | Filed by the company against The Oriental Insurance Company Ltd., and 1 other | Disposed |
| Calcutta High Court | Writ petition | Filed by the company against State of West Bengal & Ors | Disposed |
To see the full case history of Provet Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Provet Pharma Private Limited was last rated by Crisil on 01 Jul 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 01 Jul 2021 |
To see the full credit ratings and regulatory alerts of Provet Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Provet Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Provet Pharma Private Limited has a workforce of 116 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
116
Active EPFO establishments
1
Employee growth
-25.64%
GST
Provet Pharma has 9 GST registrations: 8 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
9
Active
8
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCP2048B1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
| 06AAFCP2048B1ZW | Haryana | Active | 01 Jul 2017 |
| 19AAFCP2048B1ZP | West Bengal | Active | 01 Jul 2017 |
| 27AAFCP2048B1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Provet Pharma Private Limited, buy the company report.
Recent activity
Provet Pharma Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Sukakumar Puvi Kumar ceased to be Additional Director on 25 Sep 2018.
AGM
Provet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 2,602.86 Lakh registered on 25 Dec 2021 with Charge ID 100521181 was modified on 28 Jul 2025.
Filing
Provet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge registered on 02 Mar 2022 via Charge ID 100560773 with Others was fully satisfied on 25 Apr 2024.
Charges
A charge with Others amounted to Rs. 250.00 Lakh with Charge ID 100560773 was registered on 02 Mar 2022.
Charges
A charge registered on 07 Mar 2017 via Charge ID 100107021 with Others was fully satisfied on 09 Feb 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,602.86 Lakh with Charge ID 100521181 was registered on 25 Dec 2021.
Charges
A charge with Others of Rs. 1,603.18 Lakh registered on 07 Mar 2017 with Charge ID 100107021 was modified on 22 Jul 2020.
Ceased
Sukakumar Puvi Kumar ceased to be Additional Director.
Ceased
Sukakumar Somasundaram ceased to be Director.
Charges
A charge registered on 28 Apr 2010 via Charge ID 10218570 with Indian Bank was fully satisfied on 04 Jul 2017.
Charges
A charge with Others amounted to Rs. 1,603.18 Lakh with Charge ID 100107021 was registered on 07 Mar 2017.
8 earlier events are in the company report.
Frequently asked questions
Provet Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 14 October 2009 (17+ years old) and is registered under CIN U24231TN2009PTC073198.
Provet Pharma has 2 current directors:
- Muthu Selvan Vengan - Managing Director
- Suthanthirakumar Senthil - Director
The latest financial statements of Provet Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Provet Pharma is 33AAFCP2048B1ZZ, registered in Tamil Nadu. The company has 9 GST registrations in all, of which 8 are active and 1 is cancelled or inactive. Other active GSTINs include 06AAFCP2048B1ZW (Haryana), 19AAFCP2048B1ZP (West Bengal), 27AAFCP2048B1ZS (Maharashtra).
The CIN (Corporate Identification Number) of Provet Pharma is U24231TN2009PTC073198. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Provet Pharma has 2 court cases on record: 2 filed by the company. Most are in the district courts.
Provet Pharma was incorporated on 14 October 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
Provet Pharma has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1.09 Cr; the latest was in March 2015.
The peers of Provet Pharma by revenue are Panchsheel Organics Limited, Ayurvet Limited, Indovax Private Limited, Baader Schulz Laboratories Private Limited, Micro Animal Health Care Private Limited and 2 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sukakumar Puvi Kumar ceased to be Additional Director on 25 Sep 2018. Sukakumar Somasundaram ceased to be Director on 06 Jul 2017. Muthu Selvan Vengan ceased to be Director on 01 Apr 2015. Provet Pharma has 7 board changes on record in total.
Yes, Provet Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0020322).